The global blood plasma-derived products market has shown consistent growth over

the period 2002-2009 and the rapid increase in cases of Hemophilia, low treatme
nt cost to patients and rising ageing population are the major factors that will
be driving the market for plasma-derived products in coming years.
Immunoglobulin (IVIG) and albumin account for the largest share of the global pl
asma market. The demand for blood albumin has increased over the years due to gr
owing usage of albumin as a cell culture medium ingredient, antioxidant and also
as the most effective volume expander in critical care conditions such as liver
disease and hemorrhagic stroke. Another significant factor in albumin demand ha
s been growing needs from emerging markets like China which has started importin
g albumin from Western companies. CSL and Baxter currently are the biggest plasm
a fractionation companies.
Factor VIII account for a major portion of plasma-derived clotting factor and la
ck of which causes Hemophilia A. Demand for genetically engineered recombinant F
actor VIII (rFVIII) is also increasing as they carry less risk of carrying viral
strains and plasma-borne diseases. Baxter has the largest market share in rFVII
I market.
If you no more about Human Albumin and Factor Vlll (FVIII) Markets An Analysis r
eports then just click here http://www.konceptanalytics.com/reportDetail.aspx?re
portID=298
Website http://www.konceptanalytics.com/

1. Global Plasma Derivatives Market

1.1 Overview
1.2 Market Size
1.3 Plasma Market by Product
1.4 Plasma Market by Region
2. Albumin
2.1 Global Albumin Market
2.1.1 Overview
3. Factor VIII Market
3.1 Global Plasma Derived Factor VIII Market
3.1.1 Breakdown by Types
3.1.2 Market Size
3.1.3 Average Selling Prices
4. Market Drivers
4.1 Rising Incidences of Hemophilia
4.2 Low cost of Therapy
5. Challenges
5.1 Stringent Regulations
5.2 Ensuring Adequate Supply of Plasma
6. Company Profiles - Albumin and Factor VIII
6.1 Grifols
6.1.1 Business Description
7. Market Outlook
7.1 Forecast Methodology
7.1.1 Dependent and Independent Variables
7.1.2 Correlation Analysis

List of Graphs
Blood Plasma Constituents
Proteins Present in Human Plasma
Global Fractionation Capacities: (2009A-2013E)
Global Plasma-Derived Products Market (2002-2009)
Market Shares of Plasma Product Segments (2009)
Global Plasma Protein Market by Region (2009)
Global Albumin Market Size (2003-2009)
Albumin Global Demand Development (2003-2009E)
Average Selling Price of Albumin- Worldwide (1998-2009E)
Geographical segmentation of Global Albumin Market (2008)
Collected Source Plasma in the US (2003-2009)
US Albumin market by Albumin strength (2009)
Monthly Supply of Albumin 25% in the US (Jun 09 May 10)
Monthly Supply of Albumin 5% in the US (Jun 09 May 10)
Average Selling Price of Albumin- The US (1998-2009E)
CMS Reimbursements for Albumin in the US
The US Albumin Market Players: (2009)
Plasma Collection Volumes in China, 2003-2009E
China Albumin Market (2001-2009)
Product Share of Blood Products in China (2009)
Market Shares of Major Albumin Players- China (2009)
Breakdown of Global Plasma-Derived Clotting Factors Market (2008)
Breakdown of Factor VIII by Types: (2008)
Worldwide FVIII Usage per Capita Comparison (2009)
Plasma-Derived Factor VIII Global Market (2002-2009)
pd FVIII Global Demand Development (2003-2008)
Average Selling Price of FVIII Worldwide (1998-2009E)
Breakdown of rFVIII by Types of Products (2009)
Market Size of rFVIII- Worldwide (2000-2009)
CMS Reimbursements Comparison of FVIII and r FVIII (1Q09-1Q11)
Market Shares of rFVlll Companies (2009)
Worldwide Hemophiliac Patients (2001-2009)
Breakdown of Bleeding Disorders Identified By Types: (2009)
Global Hemophilia Market (2009-2014E)
Number of Identified Patients (All Bleeding Disorders): 2001-2009
Ageing Population Worldwide (age>65) 2005-2015F
Net Revenue of Grifols (2007-2010)
Baxter Net Revenue (2005-2010)
Annual Revenues of CSL Limited (2005-2010)
Annual Revenues of Talecris (2005-2010)
Global Plasma Derived FVlll Forecast (2009A-2014F)
Global Blood Albumin Forecast (2009A-2014F)
List of Tables
Yearly Consumption of the Plasma Products per Million People
Types of rFVIIIs
Range Of Factor VIII and Factor IX Activity
Cost to Patients IVIG vs Albumin
Dependent & Independent Variables (2004 2009)
Correlation Table
Model Summary Coefficient of Determination
Regression Coefficients Output

If you no more about Human Albumin and Factor Vlll (FVIII) Markets An Analysis r
eports then just click here http://www.konceptanalytics.com/reportDetail.aspx?re
portID=298
Website http://www.konceptanalytics.com/